What to Know About the USPTO’s Duty of Candor Guidance Regarding FDA Submissions
Fish & Richardson Trademark & Copyright Thoughts
SEPTEMBER 16, 2022
Preserving confidentiality and privilege. Procedures may also be developed for inclusion on the company’s “due diligence” checklist for patent, product, or company acquisitions and/or sales involving FDA-regulated products. Developing patent prosecution strategies to facilitate compliance with the Notice.
Let's personalize your content